Home›Companies›Biotech & Pharma›Valora Therapeutics

Valora Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 24, 2024·Suggest an edit

About Valora Therapeutics

Valora Therapeutics is a private company based in LA Jolla, California, incorporated in 2023 in Delaware. It has reported $13,039,726 raised in one offering on Form D since July 2024. Its chief executive is Miguel Garcia-Guzman.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 9, 2024Jul 24, 2024$13,039,726of $29.1M target12$1.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Valora Therapeutics's Form D filed Jul 24, 2024.

MG
Miguel Garcia-Guzman
Chief Executive Officer and director
Also a director at Rakuten Medical.
SH
SM

Sources

  1. SECValora Therapeutics, Inc. filing history